Drugs Brain and Behavior (DDP)
clinical trial
Press Enter · cited answer in seconds
0 sources
Key Facts
- Country: United States[1]
- Start time: November 1, 2020[2]
- End time: April 1, 2024[3]
- Number of participants: 160[4]
- Title: Drugs Brain and Behavior[5]
- Short name: DDP[6]
- Minimum age: 18[7]
- Maximum age: 35[8]
- Research intervention: Category:Methamphetamines[9], stimulant[10], peripheral nervous system agent[11], dopaminergic[12], neurotransmitter agent[13], mechanism of action[14], adrenergic agent[15], adrenergic uptake inhibitors[16], membrane transport modulator[17], dopamine reuptake inhibitor[18]
- Clinical trial phase: phase I clinical trial[19]
- Research site: University of Chicago[20]
- Research subject recruitment status: recruiting[21]
- Study type: interventional study[22]